About the Authors
- Zhiqiang Liu
-
Contributed equally to this work with: Zhiqiang Liu, Jingda Xu
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Jingda Xu
-
Contributed equally to this work with: Zhiqiang Liu, Jingda Xu
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Haiyan Li
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Yuhuan Zheng
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Jin He
-
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Huan Liu
-
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Yuping Zhong
-
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Yong Lu
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Bangxing Hong
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Mingjun Zhang
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Pei Lin
-
Affiliation Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Juan Du
-
Affiliation Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China
- Jian Hou
-
Affiliation Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China
- Jianfei Qian
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Larry W. Kwak
-
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
- Qing Yi
-
Affiliation Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America
- Jing Yang
-
* E-mail: jiyang@mdanderson.org
Affiliation Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: JY QY. Performed the experiments: ZL JY J. He. Analyzed the data: JX H. Li Y. Zheng J. He H. Liu Y. Zhong YL BH MZ JQ ZL JY.. Contributed reagents/materials/analysis tools: PL JD J. Hou LWK. Wrote the manuscript: JY. Larry W. Kwak.